News
ACB
2.990
+0.34%
0.010
Aurora Cannabis Shareholders Approve Board as Fiscal 2026 Results Beat Outlook
NASDAQ · 2d ago
Aurora Cannabis (ACB) Gets a Buy from Canaccord Genuity
TipRanks · 3d ago
Analysts Conflicted on These Healthcare Names: Aurora Cannabis (ACB), Biodesix (BDSX) and Insulet (PODD)
TipRanks · 3d ago
Aurora Cannabis Q1 Earnings Call Highlights
NASDAQ · 4d ago
Aurora Cannabis gains after Q1 results on outlook
Seeking Alpha · 4d ago
Aurora Cannabis 1Q Loss Narrows Despite Fall in Revenue
Dow Jones · 4d ago
Aurora Cannabis reports Q1 revenue C$67.6M vs. C$74.1M last year
TipRanks · 4d ago
*Aurora Cannabis: Outlook Now Capitalizes on Decisions Taken to Exit Low-Margin Canadian Consumer, Plant Propagation Businesses
Dow Jones · 4d ago
*Aurora Cannabis 1Q Medical Cannabis Net Rev C$64M, a 1% Decrease
Dow Jones · 4d ago
*Aurora Cannabis FY27 Outlook Unchanged
Dow Jones · 4d ago
Aurora Cannabis Q1 EPS $(0.05) Beats $(0.13) Estimate, Sales $48.798M Miss $50.510M Estimate
Benzinga · 4d ago
Aurora Cannabis reports Q1 results
Seeking Alpha · 4d ago
Press Release: Aurora Cannabis Announces Fiscal -3-
Dow Jones · 4d ago
Press Release: Aurora Cannabis Announces Fiscal 2027 First Quarter Results
Dow Jones · 4d ago
Stocks in play: Aurora Cannabis Inc.
Barchart · 4d ago
Here are the major earnings before the open Wednesday
Seeking Alpha · 5d ago
Aurora Cannabis Q1 Preview: What to expect
Seeking Alpha · 5d ago
Weekly Report: what happened at ACB last week (0727-0731)?
Weekly Report · 6d ago
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Aurora Cannabis (ACB), Eli Lilly & Co (LLY) and Tyra Bioscience (TYRA)
TipRanks · 07/27 13:40
Aurora Cannabis Wins ISS Backing Ahead of August 2026 Shareholder Meeting
TipRanks · 07/27 11:57
More
Webull provides a variety of real-time ACB stock news. You can receive the latest news about Aurora Cannabis Inc through multiple platforms. This information may help you make smarter investment decisions.
About ACB
Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution and sale of cannabis and cannabis-derivative products in Canada and internationally. The Company's segments include Cannabis and Plant Propagation. Its adult-use brand portfolio includes Drift, San Rafael '71, Daily Special, Tasty's, Being and Greybeard. The Company's medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, IndiMed and CraftPlant. Its subsidiaries include Aurora Cannabis Enterprises Inc., Aurora Deutschland GmbH, Whistler Medical Marijuana Corporation, and Indica Industries Pty Ltd., among others. The Company is engaged in distribution wholesale medical cannabis in various international markets, including Australia, New Zealand, and the Caribbean. It has manufacturing facilities in Canada and Germany.